Sale of 3,143 shares at $358.4182 per share.
Reporting Person Krishnan Krish S · Officer Title President and CEO · Transaction Code S
Traded Sep 4, 2026 · Disclosed Sep 4, 2026
Source: SEC Form 4 · 0001298709-26-000011 · filed 2026-09-04 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Krystal Biotech, Inc. (KRYS)." Disclosed 2026-09-04. https://desqlong.com/cards/0001298709-26-000011-5 (retrieved 2026-09-26).